Hassanat T. Fayemo

Hassanat T. Fayemo

Auto-generated profile, based on publicly available information

Hassanat T. Fayemo

Department of Biochemistry, Faculty of Life Sciences University of Ilorin Ilorin Nigeria

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 May 2026 in Next Materials
Verified
Journal Article
Open access
KAKamoru A. Adedokun
Kamoru A. Adedokun
HFHassanat T. Fayemo
Hassanat T. Fayemo
GOGbadebo Maroof Oyeniyi
Gbadebo Maroof Oyeniyi
ABAminah Bello
Aminah Bello
OOOluwaseun Adenike Orugun
Oluwaseun Adenike Orugun
PAPelumi Daniel Adewole
Pelumi Daniel Adewole
Modern drug discovery is undergoing a transformative shift driven by the integration of molecular, cellular, genomic, and immunological approaches. This review provides a comprehensive overview of cutting-edge methodologies that are reshaping target identification and therapeutic development, including multi-omics profiling, CRISPR–Cas functional genomics, high-throughput sequencing, and bioinformatics-driven network analysis. We highlight how these approaches enable precise dissection of disease-relevant biological mechanisms, facilitate validation of drug targets, and improve experimental efficiency in both in vitro and in vivo systems. Beyond discovery, we emphasize translational applications, illustrating the clinical potential of CRISPR/Cas9 in cancer therapy and lessons learned from rare and complex diseases such as sickle cell disease, transfusion-dependent beta-thalassemia, and Alzheimer’s disease. Additionally, the review explores advances in therapeutic antibodies, engineered biologics, and antibody–drug conjugates, detailing experimental strategies for their design, optimization, and mechanistic evaluation. By integrating experimental innovation with computa­tional modeling, this work bridges fundamental molecular insights with clinical relevance, providing a frame­work for rational drug development. Designed as both an educational resource for newcomers and a practical guide for experienced researchers, the review emphasizes mechanistically grounded, clinically translatable strategies that accelerate modern drug discovery and precision medicine, offering a forward-looking perspective on the integration of emerging technologies into next-generation therapeutics.

26 December 2023
Verified
Preprint
Open access
PDF file
HFHassanat Fayemo
Hassanat Fayemo
A good job, well done to these erudite researchers. I noticed the research design is more prophylactic rather than curative, and since the findings conclude prevention, I believed it should rather reflect in the title. I suggest 'Anticonvulsant' shou...